✦ LIBER ✦

Analysis of polypharmacy in patients with mild CF lung disease assigned to placebo in phase 3 clinical trial of denufosol

✍ Scribed by F.J. Accurso; T. Durham; T. Navratil; C. Deans; N. Herje; L. Smiley; A. Schaberg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

47 Denufosol tetrasodium inhalation solu

✍ L. Smiley; A. Rossi; D. Mathews; J. Engels; A. Schaberg; D. Kellerman; C. Shaffe 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Potential of denufosol as an early inter

✍ F.J. Accurso; W. Tian; A. Schaberg; T. Navratil; M.S. Howenstine; T.G. Liou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Experience using centralized spirometry

✍ C.H. Goss; E.F. McKone; D. Mathews; D. Kerr; J.S. Wanger; S.P. Millard 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Results from CONNECTION: A global, Phase

✍ Rachelle S. Doody; Pierre Tariot; Jeff Cummings; Bengt Winblad; Bryan Selby; And 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Effects of solanezumab versus placebo ad

✍ Dean, Robert; Siemers, Eric; Carlson, Christopher; Estergard, Wahiba; Sundell, K 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB

O3-04-05: Clinical trials of bapineuzuma

✍ Michael Grundman; Ronald Black 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB